Wildon Farwell - Net Worth and Insider Trading

Wildon Farwell Net Worth

The estimated net worth of Wildon Farwell is at least $5 Million dollars as of 2024-10-05. Wildon Farwell is the Chief Medical Officer of Dyne Therapeutics Inc and owns about 143,222 shares of Dyne Therapeutics Inc (DYN) stock worth over $5 Million. Details can be seen in Wildon Farwell's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Wildon Farwell has not made any transactions after 2024-08-19 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Wildon Farwell

To

Wildon Farwell Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Wildon Farwell owns 1 companies in total, including Dyne Therapeutics Inc (DYN) .

Click here to see the complete history of Wildon Farwell’s form 4 insider trades.

Insider Ownership Summary of Wildon Farwell

Ticker Comapny Transaction Date Type of Owner
DYN Dyne Therapeutics Inc 2024-08-19 Chief Medical Officer

Wildon Farwell Latest Holdings Summary

Wildon Farwell currently owns a total of 1 stock. Wildon Farwell owns 143,222 shares of Dyne Therapeutics Inc (DYN) as of August 19, 2024, with a value of $5 Million.

Latest Holdings of Wildon Farwell

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
DYN Dyne Therapeutics Inc 2024-08-19 143,222 32.58 4,666,173

Holding Weightings of Wildon Farwell


Wildon Farwell Form 4 Trading Tracker

According to the SEC Form 4 filings, Wildon Farwell has made a total of 14 transactions in Dyne Therapeutics Inc (DYN) over the past 5 years, including 0 buys and 14 sells. The most-recent trade in Dyne Therapeutics Inc is the sale of 2,321 shares on August 19, 2024, which brought Wildon Farwell around $104,724.

Insider Trading History of Wildon Farwell

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Wildon Farwell Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Wildon Farwell Ownership Network

Ownership Network List of Wildon Farwell

No Data

Ownership Network Relation of Wildon Farwell

Insider Network Chart

Wildon Farwell Owned Company Details

What does Dyne Therapeutics Inc do?

Who are the key executives at Dyne Therapeutics Inc?

Wildon Farwell is the Chief Medical Officer of Dyne Therapeutics Inc. Other key executives at Dyne Therapeutics Inc include director & 10 percent owner Dirk Kersten , See Remarks Richard William Scalzo , and Chief Operating Officer Susanna Gatti High .

Dyne Therapeutics Inc (DYN) Insider Trades Summary

Over the past 18 months, Wildon Farwell made 11 insider transaction in Dyne Therapeutics Inc (DYN) with a net sale of 31,945. Other recent insider transactions involving Dyne Therapeutics Inc (DYN) include a net sale of 390,785 shares made by Dirk Kersten , a net sale of 327,516 shares made by Richard William Scalzo , and a net sale of 273,683 shares made by Susanna Gatti High .

In summary, during the past 3 months, insiders sold 2,266,072 shares of Dyne Therapeutics Inc (DYN) in total and bought 32,000 shares, with a net sale of 2,234,072 shares. During the past 18 months, 7,929,754 shares of Dyne Therapeutics Inc (DYN) were sold and 1,746,285 shares were bought by its insiders, resulting in a net sale of 6,183,469 shares.

Dyne Therapeutics Inc (DYN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Dyne Therapeutics Inc Insider Transactions

No Available Data

Wildon Farwell Mailing Address

Above is the net worth, insider trading, and ownership report for Wildon Farwell. You might contact Wildon Farwell via mailing address: C/o Dyne Therapeutics, Inc., 830 Winter Street Ma 02451.

Discussions on Wildon Farwell

No discussions yet.